search
Highlights
    Home  // . //  Oliver Wyman Health //  Slide Show: A New Role for Pharma in Healthcare Value Chain

    Slide Show: A New Role for Pharma in Healthcare Value Chain

    This illustrative example from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.

    Table of Contents

      The illustrative example below from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.

      Measuring The Value Of A Drug

      As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

      Trumpcare, ACOs, and the Way Forward

      Despite changing political winds, value-based initiatives are as relevant as ever. Read new analysis of the ACO market and insight into next, best moves.

      The Post-Pandemic Payer Mix: What Happened and What’s Next?

      We're entering the Great Unknown regarding health insurance enrollment mix.

      Payer + Provider Partnerships (2/3): Build an Integrated Financial Model

      This post is the second in a series of three this week based on a new Oliver Wyman report that explores in-depth how “partnered products”—health insurance products built around a single provider system, multi-specialty group, accountable care organization (ACO), or clinically integrated network(CIN)—are transforming US health insurance.